Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1465677rdf:typepubmed:Citationlld:pubmed
pubmed-article:1465677lifeskim:mentionsumls-concept:C0040517lld:lifeskim
pubmed-article:1465677pubmed:issue5-6lld:pubmed
pubmed-article:1465677pubmed:dateCreated1993-1-21lld:pubmed
pubmed-article:1465677pubmed:abstractTextGilles de la Tourette's syndrome (GTS) is characterized with motor and vocal tics, initiating before 21 years of age, lasting for over a year and are associated with diverse behavioral disorders. The study analyzes features of 12 our GTS patients with mean age at the onset of the disease of 12.0 years, while the exact diagnosis was established only after 9.5 years (2-33 years). In 11 out of 12 patients the disease started with motor or vocal tics, while in completely developed clinical picture of GTS the permanently present tics were associated with coprolalia (6 patients), echolalia, copropraxia (in 2 patients, respectively), attention deficits (9 patients), obsessive-compulsive disorders (8 patients) etv. The role of neuroleptic therapy was discussed according to our experience and other reported studies. In our study, haloperidol had good therapeutical effect in 64% of the treated patients.lld:pubmed
pubmed-article:1465677pubmed:languagesrplld:pubmed
pubmed-article:1465677pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1465677pubmed:citationSubsetIMlld:pubmed
pubmed-article:1465677pubmed:statusMEDLINElld:pubmed
pubmed-article:1465677pubmed:issn0370-8179lld:pubmed
pubmed-article:1465677pubmed:authorpubmed-author:Kosti?V SVSlld:pubmed
pubmed-article:1465677pubmed:authorpubmed-author:Sterni?NNlld:pubmed
pubmed-article:1465677pubmed:authorpubmed-author:Damjanovi?AAlld:pubmed
pubmed-article:1465677pubmed:issnTypePrintlld:pubmed
pubmed-article:1465677pubmed:volume120lld:pubmed
pubmed-article:1465677pubmed:ownerNLMlld:pubmed
pubmed-article:1465677pubmed:authorsCompleteYlld:pubmed
pubmed-article:1465677pubmed:pagination197-202lld:pubmed
pubmed-article:1465677pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:meshHeadingpubmed-meshheading:1465677-...lld:pubmed
pubmed-article:1465677pubmed:articleTitle[Gilles de la Tourette's syndrome].lld:pubmed
pubmed-article:1465677pubmed:affiliationClinic for Neurology UCC, Belgrade.lld:pubmed
pubmed-article:1465677pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1465677pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1465677pubmed:publicationTypeCase Reportslld:pubmed